EMA OKs BMS/bluebird bio’s CAR-T Abecma For Multiple Myeloma

Other EU Recommendations Include Astellas’s Roxadustat & BioMarin’s Vosoritide

 
• By Ian Schofield
Gene editing genes therapy concept with nurse and DNA lab technician medical laboratory
A gene therapy for multiple myeloma could soon be approved in Europe • Source: Shutterstock

More from Approvals

More from Product Reviews